comparemela.com
Home
Live Updates
Zevra Therapeutics, a Rare Disease Therapeutics Company, : comparemela.com
Zevra Therapeutics, a Rare Disease Therapeutics Company,
CELEBRATION, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (“Zevra” or the “Company” and formerly known as KemPharm,...
Related Keywords
Richardw Pascoe
,
Christophera Posner
,
Joele Frank
,
Nichol Ochsner
,
Jennifer Arcure
,
Daniel Mangless
,
Davids Tierney
,
Travisc Mickle
,
Wilkinson Brimmer Katcher
,
Matthewr Plooster
,
Zevra Therapeutics Inc
,
Company Early Access Program
,
Corium Inc
,
Drug Administration
,
Us Drug Enforcement Agency
,
Company Annual Meeting
,
Exchange Commission
,
European Medicines Agency
,
Kempharm Inc
,
Annual Meeting
,
Zevra Board
,
Zevra Therapeutics
,
Nasdaq Global Market
,
Restated Bylaws
,
New Drug Application
,
Fast Track
,
Enforcement Agency
,
Early Access Program
,
Private Securities Litigation Reform Act
,
Investigational New Drug
,
Annual Report
,
Quarterly Report
,
Tim Lynch
,
Wilkinson Brimmer
,
Nasdaq Kmph
,
Kempharm
,
comparemela.com © 2020. All Rights Reserved.